Bank of the West’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$573K Sell
1,566
-63
-4% -$22.3K 0.07% 163
2022
Q3
$527K Sell
1,629
-5
-0.3% -$1.58K 0.07% 156
2022
Q2
$530K Hold
1,634
0.07% 159
2022
Q1
$468K Sell
1,634
-139
-8% -$35.8K 0.05% 170
2021
Q4
$490K Sell
1,773
-107
-6% -$27.1K 0.05% 173
2021
Q3
$434K Buy
1,880
+370
+25% +$91.3K 0.05% 176
2021
Q2
$347K Buy
1,510
+9
+0.6% +$1.81K 0.04% 188
2021
Q1
$280K Buy
1,501
+30
+2% +$5.87K 0.03% 196
2020
Q4
$248K Sell
1,471
-152
-9% -$22.7K 0.03% 197
2020
Q3
$240K Buy
+1,623
New +$251K 0.03% 196
2014
Q3
Sell
-4,562
Closed -$284K 265
2014
Q2
$284K Sell
4,562
-1,217
-21% -$72.6K 0.04% 224
2014
Q1
$340K Sell
5,779
-401
-6% -$22.4K 0.06% 198
2013
Q4
$315K Sell
6,180
-65
-1% -$3.25K 0.05% 213
2013
Q3
$314K Buy
+6,245
New +$327K 0.06% 193

Other funds holding LLY

Bank of the West's LLY Position: Q4 2022 in Review

Bank of the West reduced its Eli Lilly (LLY) stake by 3.9% in Q4 2022, selling an estimated $22.3K and leaving 1,566 shares worth $573K. The position accounts for 0.07% of the portfolio, ranked #163.

Bank of the West first reported a position in LLY in Q3 2013 and has held it in 14 quarters since. 2,672 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • Bank of the West held 1,566 shares of Eli Lilly worth $573K as of Q4 2022.
  • Bank of the West sold 63 Eli Lilly shares in Q4 2022, an estimated $22.3K.
  • Eli Lilly made up 0.07% of Bank of the West's portfolio in Q4 2022, its #163 holding.
  • Bank of the West first reported a position in Eli Lilly in Q3 2013 and has held it in 14 quarters since.
  • 2,672 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.